Skip to main navigation

Investors

News Archive
Past Events and Presentations
Stock History

News Archive

News Archive

Items Per Page

Year

Apr 07, 2010

Mylan Receives Approval for Generic Version of NuLytely(R)

Mar 16, 2010

Mylan Announces First-to-File Opportunity Settlement Agreements for Actoplus Met(R) and Actos(R)

Mar 09, 2010

Mylan Rebukes and Cites Flaws in Bayer-Sponsored Mylan-Nifedipine Extended Release Bioequivalence Study in Canada

Mar 05, 2010

Moody's Upgrades Mylan

Mar 02, 2010

Mylan Files Annual Report on Form 10-K for Year Ended Dec. 31, 2009

Mar 02, 2010

Mylan Receives Approval for Generic Version of Actigall(R)

Feb 25, 2010

Mylan Names John D. Sheehan Chief Financial Officer

Feb 25, 2010

Mylan Reports Adjusted Diluted EPS of $0.33 for the Quarter and $1.30 for the Year Ended Dec. 31, 2009

Feb 09, 2010

Mylan Awarded NABP-VAWD Accreditation for Its Primary North American Distribution Facility

Feb 04, 2010

Mylan Confirms First-to-File Patent Challenge Relating to Caduet(R)

Pagination

First page
Previous page
…
Page 79
Page 80
Page 81
Page 82
Current page 83
Page 84
Page 85
Page 86
Page 87
…
Next page
Last page

Share

Utility Nav

Privacy Statement
Terms and Conditions

©2025 Mylan N.V. All rights reserved. The Mylan logo is a registered trademark of Mylan Inc.